The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Immunoglobulins
".
FunFam 14: H-2 class I histocompatibility antigen, alpha chai...
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 41 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Peptide antigen binding GO:0042605
Interacting selectively and non-covalently with an antigen peptide.
|
126 |
P01889 (/ISS)
P01889 (/ISS)
P01891 (/ISS)
P01891 (/ISS)
P04222 (/ISS)
P04222 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
P05534 (/ISS)
(116 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
62 |
A0A0G2K1E1 (/IPI)
A0A0G2K2E1 (/IPI)
A0A0G2K4X1 (/IPI)
A0A0G2K8G8 (/IPI)
E9PSS8 (/IPI)
P01891 (/IPI)
P01891 (/IPI)
P01892 (/IPI)
P01892 (/IPI)
P01893 (/IPI)
(52 more) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
38 |
P01891 (/ISS)
P01891 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
P05534 (/ISS)
P10314 (/ISS)
P10314 (/ISS)
P10316 (/ISS)
P10316 (/ISS)
(28 more) |
Peptide antigen binding GO:0042605
Interacting selectively and non-covalently with an antigen peptide.
|
31 |
P01892 (/IDA)
P01892 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03989 (/IDA)
P03989 (/IDA)
P03989 (/IDA)
P03991 (/IDA)
(21 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
28 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(18 more) |
Peptide antigen binding GO:0042605
Interacting selectively and non-covalently with an antigen peptide.
|
28 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(18 more) |
CD8 receptor binding GO:0042610
Interacting selectively and non-covalently with a CD8, a receptor found on the surface of thymocytes and cytotoxic and suppressor T-lymphocytes.
|
26 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(16 more) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
25 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(15 more) |
T cell receptor binding GO:0042608
Interacting selectively and non-covalently with a T cell receptor, the antigen-recognizing receptor on the surface of T cells.
|
25 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(15 more) |
TAP binding GO:0046977
Interacting selectively and non-covalently with TAP protein, transporter associated with antigen processing protein. TAP protein is a heterodimeric peptide transporter consisting of the subunits TAP1 and TAP2.
|
25 |
P01892 (/IDA)
P01892 (/IDA)
P04222 (/IDA)
P04222 (/IDA)
P04439 (/IDA)
P04439 (/IDA)
P05534 (/IDA)
P05534 (/IDA)
P10314 (/IDA)
P10314 (/IDA)
(15 more) |
Peptide binding GO:0042277
Interacting selectively and non-covalently with peptides, any of a group of organic compounds comprising two or more amino acids linked by peptide bonds.
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
TAP binding GO:0046977
Interacting selectively and non-covalently with TAP protein, transporter associated with antigen processing protein. TAP protein is a heterodimeric peptide transporter consisting of the subunits TAP1 and TAP2.
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
TAP complex binding GO:0062061
Interacting selectively and non-covalently with a TAP complex.
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
Signaling receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
7 | P01889 (/IPI) P01889 (/IPI) P01892 (/IPI) P01892 (/IPI) P13747 (/IPI) P17693 (/IPI) P17693 (/IPI) |
RNA binding GO:0003723
Interacting selectively and non-covalently with an RNA molecule or a portion thereof.
|
6 | P01891 (/HDA) P01891 (/HDA) P01892 (/HDA) P01892 (/HDA) P10316 (/HDA) P10316 (/HDA) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
6 | A0A0G2K1E1 (/IPI) A0A0G2K2E1 (/IPI) A0A0G2K4X1 (/IPI) A0A0G2K8G8 (/IPI) E9PSS8 (/IPI) Q6MGB9 (/IPI) |
Peptide binding GO:0042277
Interacting selectively and non-covalently with peptides, any of a group of organic compounds comprising two or more amino acids linked by peptide bonds.
|
6 | A0A0G2K1E1 (/IDA) A0A0G2K2E1 (/IDA) A0A0G2K4X1 (/IDA) A0A0G2K8G8 (/IDA) E9PSS8 (/IDA) Q6MGB9 (/IDA) |
Peptide antigen binding GO:0042605
Interacting selectively and non-covalently with an antigen peptide.
|
6 | P01891 (/IMP) P01891 (/IMP) P13747 (/IMP) Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
6 | A0A0G2K1E1 (/IPI) A0A0G2K2E1 (/IPI) A0A0G2K4X1 (/IPI) A0A0G2K8G8 (/IPI) E9PSS8 (/IPI) Q6MGB9 (/IPI) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
5 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) P30511 (/IDA) P30511 (/IDA) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
4 | P01891 (/IMP) P01891 (/IMP) P01893 (/IMP) P13747 (/IMP) |
CD8 receptor binding GO:0042610
Interacting selectively and non-covalently with a CD8, a receptor found on the surface of thymocytes and cytotoxic and suppressor T-lymphocytes.
|
4 | P01892 (/IDA) P01892 (/IDA) P17693 (/IDA) P17693 (/IDA) |
T cell receptor binding GO:0042608
Interacting selectively and non-covalently with a T cell receptor, the antigen-recognizing receptor on the surface of T cells.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Beta-2-microglobulin binding GO:0030881
Interacting selectively and non-covalently with beta-2-microglobulin.
|
2 | P01892 (/IC) P01892 (/IC) |
MHC class I protein binding GO:0042288
Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
|
2 | P01902 (/IPI) P01902 (/IPI) |
MHC class I protein binding GO:0042288
Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
2 | P17693 (/IPI) P17693 (/IPI) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | P17693 (/NAS) P17693 (/NAS) |
Natural killer cell lectin-like receptor binding GO:0046703
Interacting selectively and non-covalently with a lectin-like natural killer cell receptor.
|
2 | P06339 (/ISO) P06339 (/ISO) |
TAP1 binding GO:0046978
Interacting selectively and non-covalently with the TAP1 subunit of TAP (transporter associated with antigen processing) protein.
|
2 | P30511 (/IPI) P30511 (/IPI) |
TAP2 binding GO:0046979
Interacting selectively and non-covalently with the TAP2 subunit of TAP (transporter associated with antigen processing) protein.
|
2 | P30511 (/IPI) P30511 (/IPI) |
Chaperone binding GO:0051087
Interacting selectively and non-covalently with a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport.
|
2 | P30460 (/IPI) P30460 (/IPI) |
TAP complex binding GO:0062061
Interacting selectively and non-covalently with a TAP complex.
|
2 | P01892 (/IDA) P01892 (/IDA) |
14-3-3 protein binding GO:0071889
Interacting selectively and non-covalently with a 14-3-3 protein. A 14-3-3 protein is any of a large family of approximately 30kDa acidic proteins which exist primarily as homo- and heterodimers within all eukaryotic cells, and have been implicated in the modulation of distinct biological processes by binding to specific phosphorylated sites on diverse target proteins, thereby forcing conformational changes or influencing interactions between their targets and other molecules. Each 14-3-3 protein sequence can be roughly divided into three sections: a divergent amino terminus, the conserved core region and a divergent carboxy-terminus. The conserved middle core region of the 14-3-3s encodes an amphipathic groove that forms the main functional domain, a cradle for interacting with client proteins.
|
2 | P30511 (/IDA) P30511 (/IDA) |
MHC class II receptor activity GO:0032395
Combining with an MHC class II protein complex and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
|
1 | Q14838 (/NAS) |
MHC class I protein binding GO:0042288
Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation.
|
1 | P13747 (/IDA) |
Natural killer cell lectin-like receptor binding GO:0046703
Interacting selectively and non-covalently with a lectin-like natural killer cell receptor.
|
1 | P13747 (/IPI) |
There are 138 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Antigen processing and presentation of peptide antigen via MHC class I GO:0002474
The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Regulation of immune response GO:0050776
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Interferon-gamma-mediated signaling pathway GO:0060333
A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Type I interferon signaling pathway GO:0060337
A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Positive regulation of T cell mediated cytotoxicity GO:0001916
Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
|
33 |
A0A0G2K1E1 (/IDA)
A0A0G2K2E1 (/IDA)
A0A0G2K4X1 (/IDA)
A0A0G2K8G8 (/IDA)
E9PSS8 (/IDA)
P01892 (/IDA)
P01892 (/IDA)
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
(23 more) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
27 |
P01889 (/NAS)
P01889 (/NAS)
P01893 (/NAS)
P04439 (/NAS)
P04439 (/NAS)
P13746 (/NAS)
P13746 (/NAS)
P16188 (/NAS)
P30443 (/NAS)
P30443 (/NAS)
(17 more) |
Protection from natural killer cell mediated cytotoxicity GO:0042270
The process of protecting a cell from natural killer cell mediated cytotoxicity.
|
15 |
P01889 (/IDA)
P01889 (/IDA)
P05534 (/IDA)
P05534 (/IDA)
P10314 (/IDA)
P10314 (/IDA)
P13746 (/IDA)
P13746 (/IDA)
P13747 (/IDA)
P17693 (/IDA)
(5 more) |
Antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent GO:0002485
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
|
13 |
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
P01900 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03991 (/IDA)
P04223 (/IDA)
(3 more) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
13 |
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
P01900 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03991 (/IDA)
P04223 (/IDA)
(3 more) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
13 |
P01895 (/IMP)
P01899 (/IMP)
P01899 (/IMP)
P01900 (/IMP)
P01901 (/IMP)
P01901 (/IMP)
P01902 (/IMP)
P01902 (/IMP)
P03991 (/IMP)
P04223 (/IMP)
(3 more) |
Antigen processing and presentation of exogenous peptide antigen via MHC class I GO:0042590
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
|
13 |
P01892 (/IDA)
P01892 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03991 (/IDA)
P04223 (/IDA)
P04439 (/IDA)
P04439 (/IDA)
(3 more) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
10 | P01901 (/IDA) P01901 (/IDA) P01902 (/IDA) P01902 (/IDA) P03991 (/IDA) P04223 (/IDA) P14428 (/IDA) Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Neutrophil degranulation GO:0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
|
9 | P01889 (/TAS) P01889 (/TAS) P01893 (/TAS) P10321 (/TAS) P10321 (/TAS) P30453 (/TAS) P30453 (/TAS) P30459 (/TAS) P30459 (/TAS) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
9 | P01901 (/IDA) P01901 (/IDA) P01902 (/IDA) P01902 (/IDA) P03991 (/IDA) P04223 (/IDA) P06339 (/IDA) P06339 (/IDA) P14428 (/IDA) |
Antigen processing and presentation of endogenous peptide antigen via MHC class Ib GO:0002476
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
8 | P13747 (/IDA) P17693 (/IDA) P17693 (/IDA) P30511 (/IDA) P30511 (/IDA) Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent GO:0002486
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-independent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following transport from the cytosol via a TAP-independent pathway. Class I here refers to classical class I molecules.
|
8 | P01892 (/IDA) P01892 (/IDA) P03989 (/IDA) P03989 (/IDA) P03989 (/IDA) P18464 (/IDA) P18464 (/IDA) P30499 (/IDA) |
Negative regulation of natural killer cell mediated cytotoxicity GO:0045953
Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
|
8 | A0A0G2K1E1 (/IMP) A0A0G2K2E1 (/IMP) A0A0G2K4X1 (/IMP) A0A0G2K8G8 (/IMP) E9PSS8 (/IMP) P17693 (/IMP) P17693 (/IMP) Q6MGB9 (/IMP) |
CD8-positive, alpha-beta T cell activation GO:0036037
The change in morphology and behavior of a CD8-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
7 | P01892 (/IDA) P01892 (/IDA) P04439 (/IDA) P04439 (/IDA) P13747 (/IDA) P30443 (/IDA) P30443 (/IDA) |
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
|
7 | P04222 (/TAS) P04222 (/TAS) P13747 (/TAS) P30504 (/TAS) P30504 (/TAS) Q95365 (/TAS) Q95365 (/TAS) |
Antigen processing and presentation of exogenous peptide antigen via MHC class Ib GO:0002477
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
6 | P13747 (/IDA) P30511 (/IDA) P30511 (/IDA) Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
T cell tolerance induction GO:0002517
A process involving any mechanism for tolerance induction in T cells.
|
6 | A0A0G2K1E1 (/IMP) A0A0G2K2E1 (/IMP) A0A0G2K4X1 (/IMP) A0A0G2K8G8 (/IMP) E9PSS8 (/IMP) Q6MGB9 (/IMP) |
Positive regulation of tolerance induction to nonself antigen GO:0002657
Any process that activates or increases the frequency, rate, or extent of tolerance induction to nonself antigen.
|
6 | A0A0G2K1E1 (/IMP) A0A0G2K2E1 (/IMP) A0A0G2K4X1 (/IMP) A0A0G2K8G8 (/IMP) E9PSS8 (/IMP) Q6MGB9 (/IMP) |
Negative regulation of neuron projection development GO:0010977
Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
|
6 | P01895 (/IGI) P01899 (/IGI) P01899 (/IGI) P01900 (/IGI) P14426 (/IGI) P14427 (/IGI) |
Positive regulation of T cell mediated cytotoxicity GO:0001916
Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
|
5 | P30511 (/IMP) P30511 (/IMP) Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Antigen processing and presentation of endogenous peptide antigen via MHC class Ib GO:0002476
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
5 | P06339 (/ISO) P06339 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of natural killer cell cytokine production GO:0002729
Any process that activates or increases the frequency, rate, or extent of natural killer cell cytokine production.
|
5 | P13747 (/IDA) P17693 (/IDA) P17693 (/IDA) P30511 (/IDA) P30511 (/IDA) |
Positive regulation of natural killer cell cytokine production GO:0002729
Any process that activates or increases the frequency, rate, or extent of natural killer cell cytokine production.
|
5 | P06339 (/ISO) P06339 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
5 | P03989 (/IMP) P03989 (/IMP) P03989 (/IMP) P30443 (/IMP) P30443 (/IMP) |
Detection of bacterium GO:0016045
The series of events in which a stimulus from a bacterium is received and converted into a molecular signal.
|
5 | P03989 (/IMP) P03989 (/IMP) P03989 (/IMP) P30443 (/IMP) P30443 (/IMP) |
Protection from natural killer cell mediated cytotoxicity GO:0042270
The process of protecting a cell from natural killer cell mediated cytotoxicity.
|
5 | P06339 (/ISO) P06339 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Negative regulation of natural killer cell mediated cytotoxicity GO:0045953
Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
|
5 | P13747 (/IDA) P17693 (/IDA) P17693 (/IDA) P30511 (/IDA) P30511 (/IDA) |
Negative regulation of natural killer cell mediated cytotoxicity GO:0045953
Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity.
|
5 | P06339 (/ISO) P06339 (/ISO) Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
T cell mediated cytotoxicity GO:0001913
The directed killing of a target cell by a T cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
|
4 | P04439 (/IDA) P04439 (/IDA) P30443 (/IDA) P30443 (/IDA) |
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
|
4 | P01897 (/TAS) P03989 (/TAS) P03989 (/TAS) P03989 (/TAS) |
Protein ubiquitination GO:0016567
The process in which one or more ubiquitin groups are added to a protein.
|
4 | P01892 (/TAS) P01892 (/TAS) P04439 (/TAS) P04439 (/TAS) |
Antigen processing and presentation of endogenous peptide antigen via MHC class I GO:0019885
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules.
|
4 | P01892 (/IDA) P01892 (/IDA) P30443 (/IDA) P30443 (/IDA) |
Negative regulation of T cell mediated cytotoxicity GO:0001915
Any process that stops, prevents, or reduces the rate of T cell mediated cytotoxicity.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Response to molecule of bacterial origin GO:0002237
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
|
3 | Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Alpha-beta T cell activation involved in immune response GO:0002287
The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Peripheral B cell tolerance induction GO:0002451
Tolerance induction of mature B cells in the peripheral lymphoid tissues: the blood, lymph nodes, spleen, and mucosal-associated lymphoid tissue.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent GO:0002481
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
3 | Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Positive regulation of tolerance induction GO:0002645
Any process that activates or increases the frequency, rate, or extent of tolerance induction.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of T cell tolerance induction GO:0002666
Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Immune response-inhibiting cell surface receptor signaling pathway GO:0002767
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell capable of inhibiting an immune response.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Antibacterial humoral response GO:0019731
An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Antigen processing and presentation GO:0019882
The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.
|
3 | E9PX63 (/IMP) O19441 (/IMP) Q66JR0 (/IMP) |
Positive regulation of interferon-gamma production GO:0032729
Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Positive regulation of interleukin-12 production GO:0032735
Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Positive regulation of nitric oxide biosynthetic process GO:0045429
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Positive regulation of regulatory T cell differentiation GO:0045591
Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of natural killer cell mediated cytotoxicity GO:0045954
Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.
|
3 | Q0WXH3 (/IMP) Q31093 (/IMP) Q8MHM0 (/IMP) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Negative regulation of protein kinase B signaling GO:0051898
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of macrophage cytokine production GO:0060907
Any process that increases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Protein homotrimerization GO:0070207
The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Negative regulation of G0 to G1 transition GO:0070317
A cell cycle process that stops, prevents, or reduces the rate or extent of the transition from the G0 quiescent state to the G1 phase.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of endothelial cell apoptotic process GO:2000353
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of CD8-positive, alpha-beta T cell proliferation GO:2000566
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Positive regulation of cellular senescence GO:2000774
Any process that activates or increases the frequency, rate or extent of cellular senescence.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of CD8-positive, alpha-beta T cell activation GO:2001187
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
|
3 | P01892 (/IDA) P01892 (/IDA) P13747 (/IDA) |
Negative regulation of dendritic cell differentiation GO:2001199
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Positive regulation of antibody-dependent cellular cytotoxicity GO:0001815
Any process that activates or increases the frequency, rate or extent of antibody-dependent cellular cytotoxicity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Negative regulation of T cell mediated cytotoxicity GO:0001915
Any process that stops, prevents, or reduces the rate of T cell mediated cytotoxicity.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of T cell mediated cytotoxicity GO:0001916
Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Adaptive immune response GO:0002250
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
|
2 | P06339 (/ISO) P06339 (/ISO) |
T cell mediated cytotoxicity directed against tumor cell target GO:0002419
The directed killing of a tumor cell by a T cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors.
|
2 | P30443 (/IDA) P30443 (/IDA) |
Peripheral B cell tolerance induction GO:0002451
Tolerance induction of mature B cells in the peripheral lymphoid tissues: the blood, lymph nodes, spleen, and mucosal-associated lymphoid tissue.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Antigen processing and presentation of exogenous peptide antigen via MHC class Ib GO:0002477
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent GO:0002485
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP-dependent ER pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and becomes associated with the MHC class I molecule in the ER following TAP-dependent transport from the cytosol. Class I here refers to classical class I molecules.
|
2 | P01892 (/IMP) P01892 (/IMP) |
Antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent GO:0002489
The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family.
|
2 | P06339 (/IDA) P06339 (/IDA) |
Natural killer cell tolerance induction GO:0002519
Tolerance induction of natural killer cells.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of tolerance induction GO:0002645
Any process that activates or increases the frequency, rate, or extent of tolerance induction.
|
2 | P17693 (/IMP) P17693 (/IMP) |
Positive regulation of T cell tolerance induction GO:0002666
Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction.
|
2 | P17693 (/IMP) P17693 (/IMP) |
Regulation of T cell anergy GO:0002667
Any process that modulates the frequency, rate, or extent of T cell anergy.
|
2 | P01889 (/IMP) P01889 (/IMP) |
Regulation of natural killer cell mediated immunity GO:0002715
Any process that modulates the frequency, rate, or extent of natural killer cell mediated immunity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of natural killer cell mediated immunity GO:0002717
Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated immunity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Negative regulation of T cell cytokine production GO:0002725
Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell cytokine production.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Positive regulation of T cell cytokine production GO:0002726
Any process that activates or increases the frequency, rate, or extent of T cell cytokine production.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Negative regulation of natural killer cell cytokine production GO:0002728
Any process that stops, prevents, or reduces the frequency, rate, or extent of natural killer cell cytokine production.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Immune response-inhibiting cell surface receptor signaling pathway GO:0002767
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell capable of inhibiting an immune response.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Cellular defense response GO:0006968
A defense response that is mediated by cells.
|
2 | P17693 (/TAS) P17693 (/TAS) |
Negative regulation of angiogenesis GO:0016525
Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Antibacterial humoral response GO:0019731
An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Regulation of interleukin-12 production GO:0032655
Any process that modulates the frequency, rate, or extent of interleukin-12 production.
|
2 | P01889 (/IMP) P01889 (/IMP) |
Regulation of interleukin-6 production GO:0032675
Any process that modulates the frequency, rate, or extent of interleukin-6 production.
|
2 | P01889 (/IMP) P01889 (/IMP) |
Positive regulation of interferon-gamma production GO:0032729
Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Positive regulation of interleukin-12 production GO:0032735
Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of interleukin-13 production GO:0032736
Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of interleukin-4 production GO:0032753
Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of TRAIL production GO:0032759
Any process that activates or increases the frequency, rate, or extent of TRAIL production.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of tumor necrosis factor production GO:0032760
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of natural killer cell proliferation GO:0032819
Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation.
|
2 | P06339 (/ISO) P06339 (/ISO) |
CD8-positive, alpha-beta T cell activation GO:0036037
The change in morphology and behavior of a CD8-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Negative regulation of natural killer cell degranulation GO:0043322
Any process that stops, prevents, or reduces the rate of natural killer cell degranulation.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Positive regulation of natural killer cell degranulation GO:0043323
Any process that activates or increases the frequency, rate or extent of natural killer cell degranulation.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Positive regulation of regulatory T cell differentiation GO:0045591
Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
|
2 | P17693 (/IMP) P17693 (/IMP) |
Positive regulation of natural killer cell mediated cytotoxicity GO:0045954
Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Regulation of defense response to virus by virus GO:0050690
Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism.
|
2 | P01892 (/TAS) P01892 (/TAS) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
2 | P17693 (/IC) P17693 (/IC) |
Defense response to Gram-positive bacterium GO:0050830
Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
|
2 | P06339 (/ISO) P06339 (/ISO) |
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Positive regulation of immunoglobulin secretion GO:0051024
Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Protein homotetramerization GO:0051289
The formation of a protein homotetramer, a macromolecular structure consisting of four noncovalently associated identical subunits.
|
2 | Q3U531 (/IDA) Q62323 (/IDA) |
Protein heterotetramerization GO:0051290
The formation of a protein heterotetramer, a macromolecular structure consisting of four noncovalently associated subunits, of which not all are identical.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Negative regulation of protein kinase B signaling GO:0051898
Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of macrophage cytokine production GO:0060907
Any process that increases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Protein homotrimerization GO:0070207
The formation of a protein homotrimer, a macromolecular structure consisting of three noncovalently associated identical subunits.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Negative regulation of G0 to G1 transition GO:0070317
A cell cycle process that stops, prevents, or reduces the rate or extent of the transition from the G0 quiescent state to the G1 phase.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Negative regulation of neuron death GO:1901215
Any process that stops, prevents or reduces the frequency, rate or extent of neuron death.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Positive regulation of endothelial cell apoptotic process GO:2000353
Any process that activates or increases the frequency, rate or extent of endothelial cell apoptotic process.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of CD8-positive, alpha-beta T cell proliferation GO:2000566
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell proliferation.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Positive regulation of memory T cell activation GO:2000568
Any process that activates or increases the frequency, rate or extent of memory T cell activation.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Positive regulation of cellular senescence GO:2000774
Any process that activates or increases the frequency, rate or extent of cellular senescence.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of CD8-positive, alpha-beta T cell activation GO:2001187
Any process that activates or increases the frequency, rate or extent of CD8-positive, alpha-beta T cell activation.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Regulation of dendritic cell differentiation GO:2001198
Any process that modulates the frequency, rate or extent of dendritic cell differentiation.
|
2 | P01889 (/IMP) P01889 (/IMP) |
Negative regulation of dendritic cell differentiation GO:2001199
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Positive regulation of antibody-dependent cellular cytotoxicity GO:0001815
Any process that activates or increases the frequency, rate or extent of antibody-dependent cellular cytotoxicity.
|
1 | P13747 (/IDA) |
Adaptive immune response GO:0002250
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
|
1 | P13747 (/IDA) |
Natural killer cell tolerance induction GO:0002519
Tolerance induction of natural killer cells.
|
1 | P13747 (/IDA) |
Regulation of natural killer cell mediated immunity GO:0002715
Any process that modulates the frequency, rate, or extent of natural killer cell mediated immunity.
|
1 | P13747 (/IDA) |
Positive regulation of natural killer cell mediated immunity GO:0002717
Any process that activates or increases the frequency, rate, or extent of natural killer cell mediated immunity.
|
1 | P13747 (/IDA) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
1 | Q4KN81 (/IMP) |
Embryo implantation GO:0007566
Attachment of the blastocyst to the uterine lining.
|
1 | P14429 (/IDA) |
Positive regulation of interleukin-13 production GO:0032736
Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.
|
1 | P13747 (/IDA) |
Positive regulation of interleukin-4 production GO:0032753
Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
|
1 | P13747 (/IDA) |
Positive regulation of TRAIL production GO:0032759
Any process that activates or increases the frequency, rate, or extent of TRAIL production.
|
1 | P13747 (/IDA) |
Positive regulation of tumor necrosis factor production GO:0032760
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
1 | P13747 (/IDA) |
Positive regulation of natural killer cell proliferation GO:0032819
Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation.
|
1 | P13747 (/IDA) |
Multicellular organism growth GO:0035264
The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
|
1 | Q4KN81 (/IMP) |
Positive regulation of natural killer cell mediated cytotoxicity GO:0045954
Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity.
|
1 | P13747 (/IDA) |
Positive regulation of immunoglobulin secretion GO:0051024
Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
|
1 | P13747 (/IDA) |
Cellular response to interferon-gamma GO:0071346
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
|
1 | P14429 (/IDA) |
There are 49 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Phagocytic vesicle membrane GO:0030670
The lipid bilayer surrounding a phagocytic vesicle.
|
163 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P01895 (/TAS)
P01896 (/TAS)
P01897 (/TAS)
(153 more) |
Integral component of lumenal side of endoplasmic reticulum membrane GO:0071556
The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane.
|
163 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P01895 (/TAS)
P01896 (/TAS)
P01897 (/TAS)
(153 more) |
Golgi membrane GO:0000139
The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
ER to Golgi transport vesicle membrane GO:0012507
The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Recycling endosome membrane GO:0055038
The lipid bilayer surrounding a recycling endosome.
|
142 |
P01889 (/TAS)
P01889 (/TAS)
P01891 (/TAS)
P01891 (/TAS)
P01892 (/TAS)
P01892 (/TAS)
P01893 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
P03989 (/TAS)
(132 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
128 |
P01891 (/ISS)
P01891 (/ISS)
P03989 (/ISS)
P03989 (/ISS)
P03989 (/ISS)
P04222 (/ISS)
P04222 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
(118 more) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
128 |
P01891 (/ISS)
P01891 (/ISS)
P03989 (/ISS)
P03989 (/ISS)
P03989 (/ISS)
P04222 (/ISS)
P04222 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
(118 more) |
MHC class I protein complex GO:0042612
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
|
128 |
P01889 (/ISS)
P01889 (/ISS)
P01891 (/ISS)
P01891 (/ISS)
P04222 (/ISS)
P04222 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
P05534 (/ISS)
(118 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
122 |
P01889 (/ISS)
P01889 (/ISS)
P01891 (/ISS)
P01891 (/ISS)
P04439 (/ISS)
P04439 (/ISS)
P05534 (/ISS)
P05534 (/ISS)
P10314 (/ISS)
P10314 (/ISS)
(112 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
28 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(18 more) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
26 |
P01889 (/NAS)
P01889 (/NAS)
P01893 (/NAS)
P04439 (/NAS)
P04439 (/NAS)
P13746 (/NAS)
P13746 (/NAS)
P16188 (/NAS)
P30443 (/NAS)
P30443 (/NAS)
(16 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
25 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(15 more) |
MHC class I protein complex GO:0042612
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
|
25 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(15 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
Golgi medial cisterna GO:0005797
The middle Golgi cisterna (or cisternae).
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
23 |
B2RWS1 (/IDA)
P01892 (/IDA)
P01892 (/IDA)
P03989 (/IDA)
P03989 (/IDA)
P03989 (/IDA)
P04222 (/IDA)
P04222 (/IDA)
P10321 (/IDA)
P10321 (/IDA)
(13 more) |
MHC class I peptide loading complex GO:0042824
A large, multisubunit complex which consists of the MHC class I-beta 2 microglobulin dimer, the transporter associated with antigen presentation (TAP), tapasin (an MHC-encoded membrane protein), the chaperone calreticulin and the thiol oxidoreductase ERp57. Functions in the assembly of peptides with newly synthesized MHC class I molecules.
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
Endoplasmic reticulum exit site GO:0070971
An endoplasmic reticulum part at which COPII-coated vesicles are produced.
|
23 |
E9PX63 (/ISO)
O19441 (/ISO)
P01895 (/ISO)
P01898 (/ISO)
P01899 (/ISO)
P01899 (/ISO)
P01900 (/ISO)
P01901 (/ISO)
P01901 (/ISO)
P01902 (/ISO)
(13 more) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
19 |
P01889 (/HDA)
P01889 (/HDA)
P03989 (/HDA)
P03989 (/HDA)
P03989 (/HDA)
P05534 (/HDA)
P05534 (/HDA)
P10316 (/HDA)
P10316 (/HDA)
P10321 (/HDA)
(9 more) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
16 |
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
P01900 (/IDA)
P01901 (/IDA)
P01901 (/IDA)
P01902 (/IDA)
P01902 (/IDA)
P03991 (/IDA)
P04223 (/IDA)
(6 more) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
16 |
P01889 (/HDA)
P01889 (/HDA)
P04439 (/HDA)
P04439 (/HDA)
P17693 (/HDA)
P17693 (/HDA)
P30443 (/HDA)
P30443 (/HDA)
P30460 (/HDA)
P30460 (/HDA)
(6 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
13 |
P01892 (/IDA)
P01892 (/IDA)
P01895 (/IDA)
P01899 (/IDA)
P01899 (/IDA)
P01900 (/IDA)
P13747 (/IDA)
P14426 (/IDA)
P14427 (/IDA)
P17693 (/IDA)
(3 more) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
10 | P01889 (/IDA) P01889 (/IDA) P01892 (/IDA) P01892 (/IDA) P30464 (/IDA) P30464 (/IDA) P30511 (/IDA) P30511 (/IDA) Q29963 (/IDA) Q29963 (/IDA) |
MHC class I protein complex GO:0042612
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules.
|
9 | P01892 (/IDA) P01892 (/IDA) P03989 (/IDA) P03989 (/IDA) P03989 (/IDA) P13747 (/IDA) P18464 (/IDA) P18464 (/IDA) P30499 (/IDA) |
Golgi apparatus GO:0005794
A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
|
8 | P01889 (/IDA) P01889 (/IDA) P01892 (/IDA) P01892 (/IDA) P30464 (/IDA) P30464 (/IDA) Q29963 (/IDA) Q29963 (/IDA) |
Secretory granule membrane GO:0030667
The lipid bilayer surrounding a secretory granule.
|
8 | P01889 (/TAS) P01889 (/TAS) P10321 (/TAS) P10321 (/TAS) P30453 (/TAS) P30453 (/TAS) P30459 (/TAS) P30459 (/TAS) |
MHC class Ib protein complex GO:0032398
A transmembrane protein complex composed of a MHC class Ib alpha chain and, in most cases, an invariant beta2-microglobin chain, and with or without a bound peptide or lipid antigen. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
|
6 | P13747 (/IDA) P30511 (/IDA) P30511 (/IDA) Q0WXH3 (/IDA) Q31093 (/IDA) Q8MHM0 (/IDA) |
Endoplasmic reticulum membrane GO:0005789
The lipid bilayer surrounding the endoplasmic reticulum.
|
4 | P01892 (/TAS) P01892 (/TAS) P04439 (/TAS) P04439 (/TAS) |
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
3 | P03989 (/TAS) P03989 (/TAS) P03989 (/TAS) |
Cis-Golgi network membrane GO:0033106
The lipid bilayer surrounding any of the compartments that make up the cis-Golgi network.
|
3 | Q0WXH3 (/ISO) Q31093 (/ISO) Q8MHM0 (/ISO) |
Golgi membrane GO:0000139
The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Lysosomal membrane GO:0005765
The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
|
2 | P30511 (/IDA) P30511 (/IDA) |
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
|
2 | P17693 (/IDA) P17693 (/IDA) |
Golgi medial cisterna GO:0005797
The middle Golgi cisterna (or cisternae).
|
2 | P01892 (/IDA) P01892 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | Q29718 (/HDA) Q29718 (/HDA) |
Early endosome membrane GO:0031901
The lipid bilayer surrounding an early endosome.
|
2 | P30511 (/IDA) P30511 (/IDA) |
MHC class Ib protein complex GO:0032398
A transmembrane protein complex composed of a MHC class Ib alpha chain and, in most cases, an invariant beta2-microglobin chain, and with or without a bound peptide or lipid antigen. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families.
|
2 | P06339 (/ISO) P06339 (/ISO) |
Cis-Golgi network membrane GO:0033106
The lipid bilayer surrounding any of the compartments that make up the cis-Golgi network.
|
2 | P17693 (/IDA) P17693 (/IDA) |
MHC class I peptide loading complex GO:0042824
A large, multisubunit complex which consists of the MHC class I-beta 2 microglobulin dimer, the transporter associated with antigen presentation (TAP), tapasin (an MHC-encoded membrane protein), the chaperone calreticulin and the thiol oxidoreductase ERp57. Functions in the assembly of peptides with newly synthesized MHC class I molecules.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Endoplasmic reticulum exit site GO:0070971
An endoplasmic reticulum part at which COPII-coated vesicles are produced.
|
2 | P01892 (/IDA) P01892 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P01898 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
1 | Q95476 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
1 | P01893 (/IMP) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
1 | Q14838 (/NAS) |
Azurophil granule membrane GO:0035577
The lipid bilayer surrounding an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid.
|
1 | P01893 (/TAS) |